Early Trimester Maternal Serum β-hCG and PAPP-A Levels as Predictor of Hypertensive disorders of Pregnancy-Reference-Cited by-同舟云学术

Early Trimester Maternal Serum β-hCG and PAPP-A Levels as Predictor of Hypertensive disorders of Pregnancy

Published:2024-01-19 Issue:3 Volume:74 Page:231-235
ISSN:0971-9202
Container-title:The Journal of Obstetrics and Gynecology of India
language:en
Short-container-title:J Obstet Gynecol India

Author:

Sruthi Rachabattuni S.,Sarita P.,Marandi Satyabhama,Nayak Sibananda,Pati Tapasi^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13224-023-01919-9.pdf

Reference16 articles.

1. Whelton PK, Carey RM, Aronow WS, et al. 2017 guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American heart association task force on clinical practice guidelines. Hypertension. 2018;71(6):1269–324.

2. Dušica K. Belovic – biochemical markers for prediction of hypertensive disorders of pregnancy. J Med Biochem. 2019;38(1):71–82. https://doi.org/10.2478/jomb-2018-0001.

3. National Institute for Health and Clinical Excellence. Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. National Institute for Health and Clinical Excellence (2010): CG107.

4. Crispi F, Llurba E, Domínguez C, et al. Predictive value of angiogenic factors and uterine artery doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol. 2008;31:303–9.

5. Wright A. Maternal serum PAPP-A and freeβ-hCG at12, 22 and 32 weeks’ gestation in screening for pre-eclampsia. Ultrasound obstet gynecol. 2016. https://doi.org/10.1002/uog.15849.